Susan E. Andrade, Sc.D. is a Senior Research Associate at the Meyers Primary Care
Institute and a Research Associate Professor of Medicine at the University of
Massachusetts Medical School. Dr. Andrade’s research interests include
pharmacoepidemiology and health services research. A main focus of her research has been
in the area of medication adherence and use of prescription drugs in special populations
including pregnant women, children, and the elderly. As site investigator in the HMO
Research Network and lead investigator for the HMO Research Network Food and Drug
Administration (FDA) Epidemiology contract site, Dr. Andrade is involved in a number of
multi-site studies evaluating prescription drug use among pregnant women and associated
birth outcomes. Other research activities include studies evaluating adherence to
medications used in the treatment of diabetes, hyperlipidemia, seizure disorders, and
other chronic diseases. She has extensive expertise in the use of large automated health
care databases for pharmacoepidemiologic research and in the study of adverse drug
effects, drug adherence issues, and health services research. 

Articles

Link

A critical review of methods to evaluate the impact of FDA regulatory actions (with Becky A. Briesacher, Stephen B. Soumerai, Fang Zhang, Sengwee Toh, Joann L. Wagner, Azadeh Shoaibi, and Jerry H. Gurwitz), Pharmacoepidemiology and drug safety (2013)
 

Link

Drug safety data mining with a tree-based scan statistic (with Martin Kulldorff, Inna Dashevsky, Taliser R. Avery, Arnold K. Chan, Robert L. Davis, David J. Graham, Richard Platt, Denise M. Boudreau, Margaret J. Gunter, Lisa J. Herrinton, Pamala Pawloski, Marsha A. Raebel, Douglas W. Roblin, and Jeffrey S. Brown), Pharmacoepidemiology and drug safety (2013)
 

Link

Validation of an algorithm to estimate gestational age in electronic health plan databases (with Qian Li, William O. Cooper, Robert L. Davis, Sascha Dublin, Tarek A. Hammad, Pamala Pawloski, Simone P. Pinheiro, Marsha A. Raebel, Pamela E. Scott, David H. Smith, Inna Dashevsky, Katherine Haffenreffer, Karin E. Johnson, and Sengwee Toh), Pharmacoepidemiology and drug safety (2013)
 

Link

Methods of linking mothers and infants using health plan data for studies of pregnancy outcomes (with Karin E. Johnson, Sarah J. Beaton, T. Craig Cheetham, Pamela E. Scott, Tarek A. Hammad, Inna Dashevsky, William O. Cooper, Robert L. Davis, Pamala Pawloski, Marsha A. Raebel, David H. Smith, Sengwee Toh, De-Kun Li, Katherine Haffenreffer, and Sascha Dublin), Pharmacoepidemiology and drug safety (2013)
 

Link

Prevalence and trends in the use of antipsychotic medications during pregnancy in the U.S., 2001-2007: a population-based study of 585,615 deliveries (with Sengwee Toh, Qian Li, T. Craig Cheetham, William O. Cooper, Robert L. Davis, Sascha Dublin, Tarek A. Hammad, De-Kun Li, Pamala Pawloski, Simone P. Pinheiro, Marsha A. Raebel, Pamela E. Scott, David H. Smith, William V. Bobo, Jean M. Lawrence, Inna Dashevsky, Katherine Haffenreffer, and Lyndsay A. Avalos), Archives of women's mental health (2013)
 

Contributions to Books

PDF

Methodological Challenges in Describing Medication Dosing Errors in Children (with Heather A. McPhillips, Christopher J. Stille, David Smith, John Pearson, John Stull, Julia Hecht, Marlene R. Miller, and Robert Davis), Advances in Patient Safety: From Research to Implementation (2005)
 

PDF

Pharmacoepidemiology and the Elderly (with Jerry H. Gurwitz), Drugs and the Older Population (2000)